Andrew J. Lotery

What is he best known for?

The fields of study Andrew J. Lotery is best known for:

• Vascular endothelial growth factor
• Bevacizumab
• Ranibizumab

In his research, Andrew J. Lotery undertakes multidisciplinary study on Ophthalmology and Visual acuity. While working on this project, he studies both Visual acuity and Macular degeneration. While working on this project, Andrew J. Lotery studies both Macular degeneration and Bevacizumab. In his works, he conducts interdisciplinary research on Bevacizumab and Ranibizumab. His Chemotherapy research extends to Ranibizumab, which is thematically connected. In his papers, Andrew J. Lotery integrates diverse fields, such as Chemotherapy and Oncology. Andrew J. Lotery merges many fields, such as Oncology and Ophthalmology, in his writings. His Vascular endothelial growth factor study frequently links to related topics such as VEGF receptors. Andrew J. Lotery frequently studies issues relating to Vascular endothelial growth factor and VEGF receptors.

His most cited work include:

• Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma (186 citations)
• Defining response to anti-VEGF therapies in neovascular AMD (182 citations)

What are the main themes of his work throughout his whole career to date

His Mutation study focuses on Missense mutation and Gene mutation. He integrates Missense mutation and Mutation in his research. He is investigating Bevacizumab as part of his Ranibizumab and Aflibercept and Bevacizumab study. Andrew J. Lotery integrates many fields, such as Cohort study, Prospective cohort study and Cohort, in his works. His Prospective cohort study study typically links adjacent topics like Surgery. His Surgery study frequently links to adjacent areas such as Refractive error. He connects Cohort with Cohort study in his research. He performs integrative Ophthalmology and Neuro-ophthalmology research in his work. He merges Neuro-ophthalmology with Glaucoma in his study.

Andrew J. Lotery most often published in these fields:

• Ophthalmology (78.57%)
• Gene (42.86%)
• Genetics (42.86%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.